09:16 ET TEVA Teva Pharm: FDA approves ANDA for Amoxicillin (78.69) Announces that the FDA has approved TEVA's ANDA for Amoxicillin for Oral Suspension, which is the generic equivalent of GSK's broad spectrum antibiotic Amoxil for Oral Suspension; branded product has annual sales of about $63 mln.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.